Compare SKYW & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKYW | STVN |
|---|---|---|
| Founded | 1972 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | 1994 | 2021 |
| Metric | SKYW | STVN |
|---|---|---|
| Price | $96.88 | $19.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $123.67 | $25.67 |
| AVG Volume (30 Days) | ★ 437.5K | 371.6K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | ★ 33.20 | N/A |
| EPS | ★ 2.50 | N/A |
| Revenue | ★ $2,971,963,000.00 | N/A |
| Revenue This Year | $8.35 | $9.67 |
| Revenue Next Year | $3.55 | $9.99 |
| P/E Ratio | $38.76 | ★ $27.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $77.89 | $12.89 |
| 52 Week High | $123.94 | $28.00 |
| Indicator | SKYW | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 62.88 | 61.94 |
| Support Level | $95.31 | $13.58 |
| Resistance Level | $101.95 | $19.41 |
| Average True Range (ATR) | 2.91 | 0.88 |
| MACD | 0.54 | 0.14 |
| Stochastic Oscillator | 63.30 | 99.27 |
SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. SkyWest generally provides regional flights and utilizes smaller, lower-cost aircraft to carry passengers who book tickets through partner airlines. It partners with carriers to fly and operate aircraft for a fee and may use the carriers' brands and ground support to coordinate marketing and transport passengers. The company has two reportable segments: SkyWest Airlines and SWC, which generate maximum revenue, and SkyWest Leasing activities.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.